logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Aggressive B-cell NHL: pixantrone+rituximab delivers nonsignificant PFS improvement

All patients had failed a prior rituximab-containing regimen.